# Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19

> **NCT04397588** · — · UNKNOWN · sponsor: **Rennes University Hospital** · enrollment: 300 (estimated)

## Conditions studied

- ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2
- Acute Refractory Heart Failure Related to SARS-CoV 2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04397588
- **Lead sponsor:** Rennes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-21
- **Primary completion:** 2020-10-21
- **Final completion:** 2020-10-21
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04397588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04397588, "Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04397588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*